pentazocine has been researched along with Retinal Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollinger, KE; Fields, T; Gonsalvez, GB; Kim, L; Mysona, BA; Qureshi, A; Smith, SB; Zhao, J | 1 |
| Dun, Y; Duplantier, J; Ganapathy, V; Martin, PM; Mysona, B; Roon, P; Smith, SB | 1 |
2 other study(ies) available for pentazocine and Retinal Degeneration
| Article | Year |
|---|---|
(+)-Pentazocine Reduces NMDA-Induced Murine Retinal Ganglion Cell Death Through a σR1-Dependent Mechanism.
Topics: Animals; Apoptosis; Blotting, Western; Cell Count; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; In Situ Nick-End Labeling; Injections, Intraperitoneal; Intravitreal Injections; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Methylaspartate; Narcotic Antagonists; Pentazocine; Receptors, sigma; Retinal Degeneration; Retinal Ganglion Cells; Sigma-1 Receptor | 2016 |
In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Ligands; Mice; Mice, Inbred C57BL; Pentazocine; Receptors, sigma; Retinal Degeneration; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Sigma-1 Receptor | 2008 |